Navigation Links
STAAR Surgical Reports 14% Fourth Quarter Revenue Growth
Date:3/16/2009

r of Parallax Medical Systems, Inc. subsequent to year end. Also included in other operating expenses for the full year is the $3,850,000 loss on settlement of preexisting distribution arrangement recorded in connection with the purchase of STAAR Japan.

For the quarter ended January 2, 2009, net loss was $9.5 million or $0.32 per share, compared with $4.3 million or $0.15 for the fourth quarter of 2007. The per share loss associated with the patent impairment charge and the jury verdict was $0.03 and $0.17, respectively. Non-cash expenses for the quarter were $2.6 million. For the year ended January 2, 2009, the net loss was $23.2 million or $0.79 per share, compared with $16.0 million or $0.57 for the year ended December 28, 2007. The net loss per share associated with other operating expenses was $0.38. Total non-cash expenses, including those associated with STAAR Japan were $11.0 million during 2008, versus $2.1 million during 2007.

At January 2, 2009, cash and cash equivalents were $5.0 million, compared to $10.9 million at December 28, 2008. During the quarter the Company used $991,000 of cash for operating activities compared with $3.4 million in the first quarter of 2008, $2.8 million in the second quarter of 2008 and $1.1 million in third quarter of 2008 and $1.7 million in the fourth quarter of 2007. Cash used in operating activities for the year ended January 2, 2009 was $8.2 million compared with the $11.2 million reported for the prior year. STAAR Japan used $477,000 and $3.4 million in cash for operating activities for the three and 12 months ended January 2, 2009, respectively. Excluding Japan, for the full year, cash used in operating activities has declined 58% from the amount used during 2007.

Conference Call

The Company will host a conference call and webcast on Monday, March 16, 2009 at 4:30 p.m. Eastern Time to discuss the Company's fourth quarter an
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
2. STAAR Surgical Reports 33% Third Quarter Revenue Growth
3. STAAR Surgical to Present at the Noble Financial Equity Conference
4. STAAR Surgicals Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification
5. STAAR Surgicals LASIK Alternative Expands U.S. Market Gains
6. STAAR Surgical Reports Solid First Quarter Progress
7. STAAR Surgical Announces First Quarter 2008 Earnings Release Date and Conference Call
8. STAAR Surgical Plans Major Presence at ASCRS
9. STAAR Surgical Reports Fourth Quarter and Year End Results
10. STAAR Surgicals Visian ICL Procedure Performed Live on NBCs Today show
11. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located ... the number one best large hotel for families in the ... their annual Travelers’ Choice Awards. , TripAdvisor represents the ... home to millions of unbiased and honest traveler reviews. The ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together by ... up to 30lbs in less than 12 weeks without traditional ... prompting an investigative review. , “Our Incredible Bulk review ... that allows the body to pack on a massive amount ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 The federal ... in the U.S. District Court, Southern District of West Virginia ... Inc. in that proceeding’s first bellwether trial. In an Order ... a new trial after finding that C.R. Bard had not ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... A study recently published in ... Medicine & Science in Sports & Exercise shows ... reduce gastrointestinal (GI) problems associated with physical strain ... the double-blind, placebo-controlled study took 10 grams of ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... with Life ... Insurance Awareness Month, PHILADELPHIA, Sept. 4, 2007 ... complex and confusing -- half don,t know how much to buy ... consumers learn,more about life insurance, CIGNA Group Insurance has created a ...
... tips to rid homes of common allergens, OMAHA, Neb., ... our time indoors getting bombarded by contaminants and,allergens, such as ... are built so air-tight that any air that gets in ... making your housekeeping,practices all the more important. Try to ...
... More Precisely Stage, Diagnose ... and Treat Lung Cancer, ... US-based organization devoted exclusively to,patient support and advocacy for those living ... investigators of the,International Association for the Study of Lung Cancer (IASLC) ...
... move more and eat smart, BOSTON, Sept. 4 ... report that again this year, obesity rates climbed in,31 ... Foundation(R) (AOMF),and YMCA of the USA,s YMCA Activate America(R) ... highlighting the,benefits of healthy, active living., AOM,s research-based ...
... Despite recommendations for annual preventive exams for adolescents, only 10 ... receive the recommended three shots needed for HPV vaccine. Ideally ... 1 percent of teens see their physicians that often. ... need all three shots before they are exposed to the ...
... OVATION Pharmaceuticals, Inc. announced the initiation of ... a unique 1,5 benzodiazapine with significant anticonvulsant properties, ... (LGS), one of the most severe forms of ... previous studies clobazam was shown to be well ...
Cached Medicine News:Health News:CIGNA Group Insurance Shows Consumers 'There's More to Life' Through a New Consumer Education Toolkit 2Health News:CIGNA Group Insurance Shows Consumers 'There's More to Life' Through a New Consumer Education Toolkit 3Health News:Clean to Ease Allergy and Asthma Symptoms 2Health News:LCA Hails International Investigators Studying Lung Cancer 2Health News:America On the Move and More Than 1,500 YMCAs Kick Off Steptember 2007 2Health News:America On the Move and More Than 1,500 YMCAs Kick Off Steptember 2007 3Health News:America On the Move and More Than 1,500 YMCAs Kick Off Steptember 2007 4Health News:Teens need to see their doctors more often 2Health News:Ovation further advances development pipeline with new phase III epilepsy study 2
(Date:1/22/2015)... RMD ) today announced results for its quarter ... million, a 10 percent increase compared to the quarter ended ... currency basis). Net income was $91.2 million, an increase of ... Diluted earnings per share for the quarter were $0.64, an ...
(Date:1/22/2015)... Jan. 22, 2015  Bio-Techne Corporation (NASDAQ: TECH ... first member of the new Simple Plex platform through ... launch represents the re-branding of the previously acquired CyPlex ... platform is a transformative immunoassay technology which integrates an ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and Markets ... of the "Infectious Disease Diagnostics Market by Product, ... report to their offering. , The ... CAGR of 7.9% to reach $18,156.2 million by 2019 ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... Calif., Dec. 14, 2010 Samplify Systems, Inc., ... for the ultrasound market, is pleased to announce ... imaging has won Electronic Design Magazine,s ... medical category.  Details of Samplify,s AutoFocus™ beamforming technology ...
... VIVUS, Inc. (Nasdaq: VVUS ) today announced ... secure regulatory approval for QNEXA® in the U.S., submitted a ... to address items in the FDA,s Complete Response Letter (CRL), ... the Endocrine and Metabolic Division of the FDA has granted ...
Cached Medicine Technology:Samplify's AutoFocus™ Beamforming Technology Awarded Electronic Design's 'Best of 2010' 2VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA® 2VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA® 3
... Experience the finest surgical-quality loupes available ... the standard for innovative optical design, ... support. Delivering optimum performance with maximum ... choice for medical professionals worldwide. All ...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... optimum performance with maximum comfort, SheerVision ... medical professionals worldwide. Make both a ...
... loupes available at manufacturer-direct prices. ... optical design, combining superior quality withunmatched ... maximum comfort, SheerVision loupes are the ... Make both a professional and a ...
... loupes available at manufacturer-direct prices. ... optical design, combining superior quality withunmatched ... maximum comfort, SheerVision loupes are the ... Make both a professional and a ...
Medicine Products: